Retatrutide 10mg – Driada Medical EU

Retatrutide 10mg by Driada Medical EU is a peptide research product containing 10mg of Retatrutide, supplied as a lyophilized (freeze-dried) peptide in a laboratory-grade vial. Manufactured under the Driada Medical EU brand, it is intended for laboratory and research applications. Retatrutide is a synthetic multi-receptor peptide that has been investigated in scientific research for its interaction with GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors.

Product Highlights

• Brand: Driada Medical EU
• Product Name: Retatrutide
• Active Compound: Retatrutide
• Strength: 10mg
• Dosage Form: Lyophilized Peptide
• Product Type: Research Peptide
• Peptide Class: Triple Receptor Agonist
• Manufactured under quality-controlled production standards

Product Information

Retatrutide is a synthetic peptide developed to interact with GLP-1, GIP, and glucagon receptors. It has been studied in laboratory and clinical research to investigate receptor activation, metabolic signaling pathways, pharmacological characteristics, and biological activity.

Driada Medical EU supplies Retatrutide 10mg as a freeze-dried peptide preparation intended for research use. The formulation, excipients, vial presentation, packaging, and batch specifications may vary depending on the manufacturer’s production process. Customers should always verify product information using the product label and official manufacturer documentation.

Scientific investigations involving Retatrutide have focused on peptide pharmacology, receptor interactions, metabolic regulation, and cellular signaling in controlled laboratory environments. These findings do not establish safety or effectiveness for unapproved medical use in humans.

Product Specifications

Storage Instructions

• Store according to the manufacturer’s recommendations.
• Refrigerate or freeze if specified on the product label.
• Protect from excessive heat, moisture, and direct sunlight.
• Keep the vial sealed until use.
• Store out of the reach of children.

Important Information

Retatrutide is supplied for research purposes, and its regulatory status varies by jurisdiction. It is not approved as an over-the-counter medicine in this formulation. Always comply with applicable laws and verify product authenticity through the manufacturer or an authorized distributor.